Annual Global Discovery to Development Innovation Forum Speakers

Christopher J Tame

Senior Principle Scientist

Chris is a medicinal chemist working across Target ID and early discovery chemistry at Benevolent AI. Currently, he is responsible for BenevolentAI’s early discovery chemistry research efforts, and is also drug discovery lead for the BenevolentAI – Astrazeneca collaboration in IPF. Prior to this, Chris spent 10 years as a medicinal chemist at GSK. During this time he contributed to the discovery of clinical candidates for IPF and COPD, as well the pioneering development of PROTAC technology, in collaboration with Craig Crews.

1 King William Street

London EC4N 7AF

hello@gbx-events.com

Tel:  0203-858-8185

Fax: 0203-858-8188

  • GBX Events
  • Gbx Events (Summit) You Tube
  • Gbx Events (Summit) Twitter

© 2019 by GBX. Proudly created with GBX Events Ltd.
Company Number: 11782795 - VAT: 317674779 UK